Angola vs Argentina: The number of people with susceptibility test result for rifampicin
Angola
33.12
in 2021
Argentina
36.41
in 2021
Angola rank
130th
Argentina rank
127th
The number of people with susceptibility test result for rifampicin over time
- Angola
- Argentina
How they compare
Argentina currently reports 36.41 against 33.12 in Angola, a difference of 3.29.
That makes Argentina's figure about 1.1 times Angola's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Argentina ahead.
Angola ranks 130th and Argentina ranks 127th of 146 countries.
Across the 2 decades both report, Angola averaged higher in 1 and Argentina in 1.
Head to head by decade
| Decade | Angola | Argentina | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 28.65 | 22.37 | 6.28 | Angola |
| 2020s | 18.32 | 30.62 | 12.29 | Argentina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Angola or Argentina?
- Argentina, at 36.41 against 33.12 in Angola as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Angola and Argentina?
- 3.29, with Argentina ahead.
- How many years of comparable data are there for Angola and Argentina?
- 5 years are reported by both, from 2017 to 2021.
- How do Angola and Argentina rank globally for the number of people with susceptibility test result for rifampicin?
- Angola ranks 130th and Argentina ranks 127th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.